Pfenex Q2 Loss Widens - Quick Facts

(RTTNews) - Pfenex Inc. (PFNX) posted second-quarter net loss attributable to common stockholders of $2.63 million or $1.67 per share, wider than $1.60 million or $1.04 per share in the comparable quarter last year.

Revenue for the latest second quarter rose to $3.27 million from $2.31 million in the year-ago period. The increase in revenue was due to an increase in activity related to the Px563L product candidate development under the company's government contracts, offset in part by a decrease in the protein production service work.

On average, three analysts polled by Thomson Reuters expected the company to report a loss of $0.17 per share on revenue of $2.12 million.